Intermediate for Tedizolid. Tedizolid (formerly torezolid, trade name Sivextro) is an oxazolidinone-class antibiotic for the treatment of acute bacterial skin and skin structure infections (also known as complicated skin and skin-structure infections (cSSSIs)). Tedizolid has been approved by the U.S Food and Drug Administration on June 20, 2014.
Product Name: (R)-3-(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one
CAS Number: 504438-22-6
Molecular Weight:  337.154
Molecular Formula:  C16H21BFNO5
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.